Regulus Therapeutics Inc Stock Nasdaq
Equities
US75915K1016
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 153M |
---|---|---|---|---|---|
Net income 2024 * | -33M | Net income 2025 * | -46M | EV / Sales 2024 * | - |
Net cash position 2024 * | 94.2M | Net cash position 2025 * | 50.8M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.61
x | P/E ratio 2025 * |
-3.84
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.25% |
Latest transcript on Regulus Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Joseph Hagan
CEO | Chief Executive Officer | 55 | 16-01-03 |
Preston Klassen
PSD | President | 55 | 23-06-21 |
Crispina Calsada
DFI | Director of Finance/CFO | 54 | 19-08-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 57 | 17-05-31 |
David Baltimore
BRD | Director/Board Member | 86 | 08-12-31 |
Director/Board Member | 75 | 13-03-31 |
1st Jan change | Capi. | |
---|---|---|
-3.08% | 102B | |
+3.03% | 96.84B | |
-1.11% | 21.48B | |
-18.33% | 20.82B | |
-8.03% | 18.6B | |
-40.70% | 16.81B | |
-26.85% | 13.78B | |
+1.28% | 13.4B | |
+21.32% | 11.06B |